These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35600601)

  • 21. Bangladesh Endocrine Society (BES) Position Statement for Management of Diabetes and Other Endocrine Diseases in Patients with COVID-19.
    Pathan F; Selim S; Fariduddin M; Rahman MH; Ashrafuzzaman SM; Afsana F; Qureshi NK; Hossain T; Saifuddin M; Kamrul-Hasan AB; Mir AS;
    Diabetes Metab Syndr Obes; 2021; 14():2217-2228. PubMed ID: 34040407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Update to the Overview of Reviews: Risks of and From SARS-COV-2 Infection and COVID-19 in People With Diabetes.
    Hartmann-Boyce J; Rees K; Onakpoya I; Otunla A; Morris E; Morgan J; Highton P; Suklan J; Curtis F; Goyder C; O'Mahoney L; James O; Sreejith N; Seidu S; Khunti K
    Diabetes Care; 2023 Dec; 46(12):e215-e216. PubMed ID: 37856358
    [No Abstract]   [Full Text] [Related]  

  • 23. A Biochemical Analysis of Patients with COVID-19 Infection.
    Sarhan AR; Hussein TA; Flaih MH; Hussein KR
    Biochem Res Int; 2021; 2021():1383830. PubMed ID: 34703628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Editorial: COVID-19 and diabetes: Current findings and future perspectives.
    Prabhakar PK
    Front Endocrinol (Lausanne); 2024; 15():1421721. PubMed ID: 38784068
    [No Abstract]   [Full Text] [Related]  

  • 25. Type 1 diabetic manifestations in a young man triggered by COVID-19.
    Dehghani Firouzabadi F; Dehghani Firouzabadi M; Moosaie F; Rafiee S; Esteghamati A
    Clin Case Rep; 2021 Jun; 9(6):e04211. PubMed ID: 34178332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of SARS-CoV-2 primary vaccines and boosters in patients with type 2 diabetes mellitus in Hungary (HUN-VE 4 Study).
    Molnár GA; Vokó Z; Sütő G; Rokszin G; Nagy D; Surján G; Surján O; Nagy P; Kenessey I; Wéber A; Pálosi M; Müller C; Kásler M; Wittmann I; Kiss Z
    BMJ Open Diabetes Res Care; 2024 Jan; 12(1):. PubMed ID: 38267204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herbal-based therapeutics for diabetic patients with SARS-Cov-2 infection.
    Rasmi Y; di Bari I; Faisal S; Haque M; Aramwit P; da Silva A; Roshani Asl E
    Mol Biol Rep; 2024 Feb; 51(1):316. PubMed ID: 38376656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 and diabetes: What do we know so far?
    Gangadaran P; Padinjarathil H; Rajendran SHS; Jogalekar MP; Hong CM; Aruchamy B; Rajendran UM; Gurunagarajan S; Krishnan A; Ramani P; Subramanian K
    Exp Biol Med (Maywood); 2022 Aug; 247(15):1330-1334. PubMed ID: 35894117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Comorbid Diabetes on Clinical Characteristics of COVID-19 Patients Infected by the Wild-Type or Delta Variant of SARS-CoV-2.
    Zhang J; Zhang J; Tao Z
    Front Endocrinol (Lausanne); 2022; 13():861443. PubMed ID: 35600601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2.
    Zhang J; Zhao D; Hu J; Huang X; Gu Q; Tao Z
    Front Public Health; 2022; 10():1049006. PubMed ID: 36466505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses.
    Thiruvengadam R; Awasthi A; Medigeshi G; Bhattacharya S; Mani S; Sivasubbu S; Shrivastava T; Samal S; Rathna Murugesan D; Koundinya Desiraju B; Kshetrapal P; Pandey R; Scaria V; Kumar Malik P; Taneja J; Binayke A; Vohra T; Zaheer A; Rathore D; Ahmad Khan N; Shaman H; Ahmed S; Kumar R; Deshpande S; Subramani C; Wadhwa N; Gupta N; Pandey AK; Bhattacharya J; Agrawal A; Vrati S; Bhatnagar S; Garg PK;
    Lancet Infect Dis; 2022 Apr; 22(4):473-482. PubMed ID: 34838183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort study.
    Schmidt M; Hajage D; Landoll M; Pequignot B; Langouet E; Amalric M; Mekontso-Dessap A; Chiscano-Camon L; Surman K; Finnerty D; Santa-Teresa P; Arcadipane A; Millán P; Roncon-Albuquerque R; Blandino-Ortiz A; Blanco-Schweizer P; Ricart P; Gimeno-Costa R; Albacete CL; Fortuna P; Schellongowski P; Dauwe D; Winiszewski H; Kimmoun A; Levy B; Hermans G; Grasselli G; Lebreton G; Guervilly C; Martucci G; Karagiannidis C; Riera J; Combes A;
    Lancet Respir Med; 2023 Feb; 11(2):163-175. PubMed ID: 36640786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of clinical characteristics between patients with seasonal influenza and patients infected by the wild type or delta variant of SARS-CoV-2.
    Zhang J; Huang X; Tao Z
    Front Public Health; 2022; 10():981233. PubMed ID: 36062112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in Clinical Characteristics Between Delta Variant and Wild-Type SARS-CoV-2 Infected Patients.
    Hu Z; Huang X; Zhang J; Fu S; Ding D; Tao Z
    Front Med (Lausanne); 2021; 8():792135. PubMed ID: 35047533
    [No Abstract]   [Full Text] [Related]  

  • 36. Humoral immune response to COVID-19 vaccination in diabetes is age-dependent but independent of type of diabetes and glycaemic control: The prospective COVAC-DM cohort study.
    Sourij C; Tripolt NJ; Aziz F; Aberer F; Forstner P; Obermayer AM; Kojzar H; Kleinhappl B; Pferschy PN; Mader JK; Cvirn G; Goswami N; Wachsmuth N; Eckstein ML; Müller A; Abbas F; Lenz J; Steinberger M; Knoll L; Krause R; Stradner M; Schlenke P; Sareban N; Prietl B; Kaser S; Moser O; Steinmetz I; Sourij H;
    Diabetes Obes Metab; 2022 May; 24(5):849-858. PubMed ID: 34984802
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.